Skip to main content
logo
Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.640
-0.030 (-1.80%)
Sep 3, 2026, 4:00 PM EDT - Market closed

Organogenesis Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
457.45564.17482.04433.14450.89467.36
Revenue Growth
6.50%17.04%11.29%-3.94%-3.52%38.15%
Gross Profit
327.02431.83366.3326.66345.87353.16
Operating Income
-28.561.5721.5216.3224.5772.94
Net Income
-101.6820.02-0.944.9515.5394.2
Earnings Per Share
-0.800.15-0.010.040.120.70
EPS Growth
----68.44%-82.94%366.67%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
46.195.92135.88104.71102.48113.93
Total Debt
66.9582.1443.31121.68126.25136.27
Net Cash (Debt)
-20.8513.7992.57-16.97-23.78-22.34
Net Cash Growth
--85.11%----
Net Cash Per Share
-0.160.110.70-0.13-0.18-0.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
31.97-10.3114.2130.9224.8661.98
Capital Expenditures
-11.13-14.15-10.03-24.36-33.9-31.22
Free Cash Flow
20.84-24.464.186.55-9.0430.76
Free Cash Flow Growth
---36.27%---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
71.49%76.54%75.99%75.42%76.71%75.56%
Operating Margin
-6.23%10.91%4.46%3.77%5.45%15.61%
Pretax Margin
-7.60%8.33%-0.58%2.40%4.50%13.50%
Profit Margin
-22.23%3.55%-0.19%1.14%3.45%20.16%
FCF Margin
4.56%-4.34%0.87%1.51%-2.00%6.58%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-32.83-108.6122.6712.62
Forward PE
-24.6758.18136.3311.9623.39
P/FCF Ratio
10.13-96.3481.96-38.65
PS Ratio
0.461.170.841.240.782.54